Sam Brusco, Associate Editor03.03.23
Convatec has gained U.S. Food and Drug Administration (FDA) clearance for its InnovaBurn placental extracellular matrix (ECM) to manage complex surgical wounds and burns, including partial-thickness second-degree burns.
InnovaBurn joins Convatec’s InnovaMatrix platform as the first placental-derived medical devices for management of burns, complex surgical wounds, and hard-to-heal wounds. The company’s InnovaMatrix PD received FDA clearance last week.
Using the company’s proprietary TriCleanse process, InnovaBurn ECM preserves the placenta’s inherent benefits.
"InnovaBurn is an innovative advancement in ECM technology for patients with partial-thickness, second-degree burns," Debra Noble, sales director of Convatec's U.S. Burn Division told the press. "InnovaBurn allows burn patients the benefits of the latest and best placental ECM technology. Our unique source material helps us to manufacture some of the largest ECM sizes in the industry much more affordably, so more patients have access to this brand new technology. Physicians tell us they appreciate the special sizing and InnovaBurn's ease of use that help them manage larger wounds like burns."
InnovaBurn is a xenograft controlled for genetic variability and lifestyle factors. The device can also be used on traumatic lacerations, dehisced incisional wounds, pressure and venous ulcers, post-Mohs surgical wounds, post-surgical incisions, and diabetic ulcers.
InnovaBurn needs no preparation, no specific placement orientation, no tissue tracking, and no special storage. It conforms and adheres to the wound site.
InnovaBurn joins Convatec’s InnovaMatrix platform as the first placental-derived medical devices for management of burns, complex surgical wounds, and hard-to-heal wounds. The company’s InnovaMatrix PD received FDA clearance last week.
Using the company’s proprietary TriCleanse process, InnovaBurn ECM preserves the placenta’s inherent benefits.
"InnovaBurn is an innovative advancement in ECM technology for patients with partial-thickness, second-degree burns," Debra Noble, sales director of Convatec's U.S. Burn Division told the press. "InnovaBurn allows burn patients the benefits of the latest and best placental ECM technology. Our unique source material helps us to manufacture some of the largest ECM sizes in the industry much more affordably, so more patients have access to this brand new technology. Physicians tell us they appreciate the special sizing and InnovaBurn's ease of use that help them manage larger wounds like burns."
InnovaBurn is a xenograft controlled for genetic variability and lifestyle factors. The device can also be used on traumatic lacerations, dehisced incisional wounds, pressure and venous ulcers, post-Mohs surgical wounds, post-surgical incisions, and diabetic ulcers.
InnovaBurn needs no preparation, no specific placement orientation, no tissue tracking, and no special storage. It conforms and adheres to the wound site.